|
|
|
26.08.25 - 22:33
|
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer (GlobeNewswire EN)
|
|
MINNEAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its Chief Financial Officer, Rick Buchholz, will be stepping down from his current position with the Company, effective December 31, 2025, in order to pursue other professional opportunities. Buchholz will remain employed with the Company in a financial advisory role through February 28, 2026, to ensure a smooth transition....
|
|
|
|
|
|
|
11.08.25 - 23:01
|
US Extends China Truce, Open to Scaled-Back Blackwell Sales | Bloomberg Businessweek Daily 8/11/2025 (Bloomberg)
|
|
On today's episode of Bloomberg Businessweek Daily, Tim Stenovec and Isabelle Lee speak with Jordan Klein, Managing Director at Mizuho Securities USA on the signal from President Trump that he would be open to allowing Nvidia Corp. to sell a scaled-back version of its most advanced AI chip to China. They also spoke with Senior Non-Resident Fellow at New York University Ed Price on Trump's extension of the 90 day trade truce with China, and upcoming summit with Russian President Vladimir Putin. Finally, Tim Herbert, president and CEO of Inspire Medical System, discussed his company's earnings and share buyback announcement. (Source: Bloomberg)...
|
|
|
|
11.08.25 - 14:03
|
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program (GlobeNewswire EN)
|
|
MINNEAPOLIS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that its Board of Directors has authorized the repurchase of up to $200 million of the company's outstanding shares of common stock....
|
|
|
|
|
|
|
|
|
|